Abatacept in IgG4-related disease: a prospective, open-label, single-arm, single-centre, proof-of-concept study

Rituximab for IgG4-related disease: a prospective, open-label trial

Mollie N. Carruthers, Mark Topazian, Arezou Khosroshahi et al. · Annals of the Rheumatic Diseases · 2015 · 709 citations

Medicine, Immunology, Pharmacotherapy +17

Clonal expansion of CD4+ cytotoxic T lymphocytes in patients with IgG4-related disease

Hamid Mattoo, Vinay S. Mahajan, Takashi Maehara et al. · Journal of Allergy and Clinical Immunology · 2016 · 416 citations · Full text

Life Sciences, Cell Biology, Immunology +16

De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease

Hamid Mattoo, Vinay S. Mahajan, Emanuel Della‐Torre et al. · Journal of Allergy and Clinical Immunology · 2014 · 386 citations · Full text

Life Sciences, Immunology, Molecular Genetics +8

Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

Jeffrey A. Sparks, Zachary S. Wallace, Andrea M. Seet et al. · Annals of the Rheumatic Diseases · 2021 · 241 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Predictors of disease relapse in IgG4-related disease following rituximab

Zachary S. Wallace, Hamid Mattoo, Vinay S. Mahajan et al. · Lara D. Veeken · 2016 · 213 citations · Full text

Medicine, Immunology, Pharmacotherapy +15